Roivant Sciences Ltd. (ROIV)
26.46
-0.30
(-1.10%)
USD |
NASDAQ |
Feb 13, 16:00
26.46
0.00 (0.00%)
After-Hours: 16:41
Roivant Sciences Total Liabilities (Quarterly) : 251.14M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Immunovant, Inc. | 66.26M |
| GSK Plc | 60.66B |
| Kiniksa Pharmaceuticals International Plc | 176.95M |
| Silence Therapeutics Plc | 72.73M |
| Adaptimmune Therapeutics Plc | 201.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.225B |
| Shareholders Equity (Quarterly) | 4.269B |
| Debt to Equity Ratio | 0.0255 |
| Current Ratio | 30.66 |
| Net Debt Paydown Yield | -0.07% |